CELLCEUTIX CORP has a total of 96 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are LATVIJAS ORGANISKAS SINTEZES I, INST MATERIA MEDICA CAMS and MEDEA RES SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | Australia | 10 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Republic of Korea | 7 | |
#5 | Taiwan | 7 | |
#6 | WIPO (World Intellectual Property Organization) | 7 | |
#7 | Canada | 4 | |
#8 | China | 4 | |
#9 | Mexico | 4 | |
#10 | Singapore | 4 | |
#11 | Brazil | 3 | |
#12 | Israel | 3 | |
#13 | South Africa | 3 | |
#14 | Argentina | 2 | |
#15 | Chile | 2 | |
#16 | EAPO (Eurasian Patent Organization) | 2 | |
#17 | Hong Kong | 2 | |
#18 | Japan | 2 | |
#19 | Malaysia | 2 | |
#20 | New Zealand | 2 | |
#21 | Ukraine | 2 | |
#22 | Hungary | 1 | |
#23 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Menon Krishna | 37 |
#2 | Scott Richard W | 35 |
#3 | Tang Haizhong | 20 |
#4 | Korczak Bozena | 16 |
#5 | Liu Dahui | 15 |
#6 | Freeman Katie | 11 |
#7 | Diamond Gill | 8 |
#8 | Pan Wenxi | 7 |
#9 | Xu Yongjiang | 6 |
#10 | Kavash Robert W | 6 |
Publication | Filing date | Title |
---|---|---|
JP2016153386A | Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of gastrointestinal tract | |
AU2014202067A1 | Nitrile derivatives and their pharmaceutical use and compositions | |
WO2014093228A1 | Antagonizing heparin with salicylamide compounds and antihistamines | |
WO2014093231A2 | Hybrid compounds and methods of making and using the same | |
AU2013242820A1 | Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof | |
SG11201404291TA | Carbocyclic nucleosides and their pharmaceutical use and compositions | |
AU2012352621A1 | Cyclic compounds and methods of making and using the same | |
KR20140147111A | Nitrile derivatives and their pharmaceutical use and compositions | |
AU2009324669A1 | Antimicrobial molecules for treating multi-drug resistant and extensively drug resistant strains of Mycobacterium |